WearOptimo, a healthcare technology company developing next-generation Microwearable sensors for hydration and biomarker monitoring, today announced three new granted patents, expanding WearOptimo's ...
Monoclonal antibodies have commercial value as research reagents, in diagnostic assays, and in therapeutic applications. Polyclonal antibodies also have potential value when large quantities of sera ...
Virtually all companies rely on their Intellectual Property to differentiate themselves as a measure of the innovation of a company. Patents are a key IP that rarely gets analyzed and is not even ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback